DLBCL After Allogeneic HCT in a Patient With Transformed DLBCL: Does It Matter Whether Relapse or PTLD?

Nathan, S., Hussain, M. J., Baptista, J., Yun, H. D., Varma, A., Vardouniotis, A., … Ustun, C. (2020, April 1). DLBCL After Allogeneic HCT in a Patient With Transformed DLBCL: Does It Matter Whether Relapse or PTLD? Clinical Lymphoma, Myeloma and Leukemia. Elsevier Inc. https://doi.org/10.1016/j.clml.2019.12.002